Dermal Fillers and Botulinum Toxin Market

1
Contrive Datum InsightsGlobal Research And
Consulting
A complete solution to explore all the potential
aspect to drive the growth of the business
industries.
Dermal Fillers and Botulinum Toxin Market
2
About Us
Contrive Datum Insights (CDI) is a market
intelligence company providing global business
information reports and services. Our exclusive
blend of quantitative forecasting and trends
analysis provides forward-looking insight for
thousands of decision makers. CDIs experienced
team of Analysts, Researchers, and Consultants
uses proprietary data sources and various tools
and techniques to gather, and analyse
information. Our business offerings represent the
latest and the most reliable information
indispensable for businesses to sustain a
competitive edge. Each CDI syndicated research
report covers a different sector such as
chemicals, materials, metals mining,
pharmaceuticals, energy, automotive, food and
beverages, semiconductors, med-devices, consumer
goods and information technology. These reports
provide in-depth analysis and deep segmentation
to possible micro levels. With wider scope and
stratified research methodology, our syndicated
reports strive to serve the overall research
requirement of clients.
3
Services O?ered

• Market Intelligence Market Opportunity
  Assessment
• Market Size Segmentation
• Market Entry Strategy
• Competitor Benchmarking
• Pricing Intelligence
• Customer Intelligence
• Sourcing Intelligence
• New-Generation Products Technologies
• Distribution Sales Channel Assessment

4
Clientele
Some of the global leading clients that we have
served
5
Clientele
Some of the global leading clients that we have
served
6
Market Overview
The global dermal fillers and botulinum toxin
market is expected to grow at a CAGR of 6.1
during the forecast period (2018-2030).

• This growth can be attributed to the growing
  demand for minimally invasive procedures and the
  prevalence of skin aging. Additionally, the
  growing demand for botulinum toxin in the
  Asia-Pacific region is another key factor fueling
  the growth of this market.
• Dermal fillers and botulinum toxin are the two
  main treatments used for cosmetic purposes.
  Dermal fillers are used to improve facial lines
  and wrinkles, while botulinum toxin is most
  commonly used to reduce crow's feet and frown
  lines.

7
Regional Insights
The US accounted for approximately 49.5 share of
the global market in 2021 and is expected to
witness continued profitability growth over the
next decade. Over the years, medical cosmetic
technology in the United States has improved
tremendously and gained traction. For patients in
need of medical assistance, the country's
advanced technology has provided a range of
products and solutions. Botulinum toxin has been
widely used in cosmetic medicine in the United
States. During the forecast period, the US market
is expected to develop rapidly owing to
increasing demand for minimally invasive cosmetic
surgery. According to FMI, Japan had a market
share of about 6.0 in 2021. Increased public
awareness and a growing younger population will
lead to greater adoption of dermal fillers and
botulinum toxin treatments. This factor is
expected to fuel the expansion of the dermal
fillers and botulinum toxin market in Japan.
8
The Dermal Fillers and Botulinum Toxin Market has
been segmented into

• By Type
• Hyaluronic Acid Based Dermal Fillers
• Non-hyaluronic Acid Based Dermal Fillers
• Botulinum Toxin
• Other

• By Application
• Aesthetic Volume Restoration
• Wrinkle Reduction
• Other

9
Strategic Developments

• On June 11, 2021, Galderma announced the launch
  of Alluzience, a ready-to-use neuromodulator or
  wrinkle reduction injectable in Europe.
  Alluzience is a precisely designed liquid version
  of botulinum toxin type A.
• On August 31, 2021, Merz Pharma launched XEOMIN
  (incobotulinum toxin A) for the symptomatic
  treatment of chronic exudates due to nervous
  system or other diseases in children and
  adolescents aged 2 to 17 years who weigh less
  than 12 kg.
• On September 11, 2019, Merz invested EUR 15
  million to expand its manufactured product range
  and strengthen its presence in Biopharma Park by
  building a new plant for Belotero dermal fillers
  in Dessau.

10
Market Players

• Allergan plc.,
• Galderma SA,
• Merz Pharma GmbH Co. KGaA,
• Sanofi, Anika Therapeutics,
• Inc., LG Life Sciences,
• Suneva Medical,Inc.,
• Hyaltech,
• Speciality European Pharma,
• HUGEL, Inc.,
• Grex Pharma SaS,
• Daewoong Pharmaceuticals,
• Medy-Tox Inc.,
• TEOXANE Laboratories,
• SciVision Biotech Inc.,
• And Others.

11
Customer Experiences
12

• By associating with Contrive Datum Insights (CDI)
  , customer can enjoy following benefits
• One-Stop-Destination for all research needs
  (Syndicate and Custom Reports)
• Reduced Budget and Faster Turnaround Time
• Focused Research Team - Contrive Datum Insights
  (CDI) can arrange a dedicated team of 2-3
  resources with 1 Research Manager , who will look
  after any ad-hoc needs of the client
• Dedicated Account Manager
• 24/7 availability for any custom needs of the
  client
• Flexible Partnering Model to accommodate clients
  research needs
• Access to Data-Cuts related to required Market
  for global region
• ? Industry Update on Weekly/Bi-Weekly/Monthly
  basis
• ? Market Trend Analysis on Monthly/Quarterly basis

Benefits of Association
13
Thank You!
To know more about us, please visit our website
www.contrivedatuminsights.com For sales queries
or new topics email us on anna_at_contrivedatuminsig
hts.com